Target intelligence / Profile preview

Hydroxyapatite–DNA surface adsorption (HAp-DNA adsorption)

Target
HAp-DNA adsorption
Molecular classification
Other
01

Overview

Hydroxyapatite–DNA surface adsorption is a physicochemical process involving the binding of deoxyribonucleic acid (DNA) to the surface of hydroxyapatite (HAp), a crystalline calcium phosphate mineral that is the primary inorganic constituent of vertebrate bone and teeth [1]. This interaction is primarily driven by electrostatic attractions between the negatively charged phosphate groups of the DNA backbone and the positively charged calcium ions (C-sites) on the HAp crystal lattice, often supplemented by hydrogen bonding [2]. While not a traditional therapeutic target such as a protein receptor or enzyme, this adsorption phenomenon is extensively utilized in biotechnology for the purification of nucleic acids via hydroxyapatite chromatography [3]. In regenerative medicine and gene therapy, HAp nanoparticles serve as non-viral delivery vehicles, where the adsorption process allows for the stable loading and protection of therapeutic DNA or RNA against enzymatic degradation [4]. Furthermore, the affinity of DNA for hydroxyapatite surfaces is significant in environmental science and archaeology, as it facilitates the long-term preservation of ancient DNA within skeletal remains [5]. Understanding the kinetics and thermodynamics of this interaction is crucial for optimizing the efficiency of gene delivery systems and improving the biocompatibility of bone-integrated medical implants [6].

Other names
DNA-hydroxyapatite bindingHAp-DNA interactionHydroxyapatite-mediated gene deliveryDNA adsorption on calcium phosphate
02

Mechanism of action

Electrostatic interaction between the negatively charged phosphate groups of the DNA backbone and the positively charged calcium ions (C-sites) on the hydroxyapatite surface.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Nanoparticle-induced inflammatory responsePotential for ectopic calcificationLow transfection efficiency in vivoPotential for DNA denaturation upon high-affinity binding
06

Interacting drugs

Plasmid DNA

3 more in the full profile.

Beyond the preview

Go deeper on Hydroxyapatite–DNA surface adsorption (HAp-DNA adsorption).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite–DNA surface adsorption (HAp-DNA adsorption).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call